Announcements Trials
Browse Landscape

Status

Completed 20Unknown 7Recruiting 5Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Genitourinary 2Endocrine 1

Conditions

Breast Neoplasms 141Neoplasms 132Prostatic Neoplasms 80Carcinoma, Non-Small-Cell Lung 80Lung Neoplasms 67Colorectal Neoplasms 47Carcinoma, Hepatocellular 37Stomach Neoplasms 32Multiple Myeloma 29Brain Neoplasms 28Uterine Cervical Neoplasms 27Pancreatic Neoplasms 26Ovarian Neoplasms 26Melanoma 25Head and Neck Neoplasms 25Rectal Neoplasms 24Colonic Neoplasms 24Urinary Bladder Neoplasms 22Neoplasm Metastasis 21Hematologic Neoplasms 21Carcinoma, Renal Cell 20Leukemia, Myeloid, Acute 19Esophageal Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Endometrial Neoplasms 17Recurrence 15Lymphoma 15Liver Neoplasms 15Cardiovascular Diseases 15COVID-19 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Observational × Prostatic Hyperplasia × Clear all
NCT05768776 2025-06-25

MOSES

University Hospital, Bordeaux

Active not recruiting
200 enrolled
EndocrineGenitourinary

Prostatic Hyperplasia, Multiple Endocrine Neoplasia Type 1

NCT04761107 2025-01-31

Impact of COVID-19 on GU Disease

Icahn School of Medicine at Mount Sinai

Active not recruiting
15,240 enrolled
Genitourinary

COVID-19, Urinary Bladder Neoplasms, Kidney Calculi, Kidney Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Tract Infections, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡